Literature DB >> 22748905

Pulmonary hypertension associated with left-sided heart disease.

Christopher F Barnett1, Teresa De Marco.   

Abstract

Pulmonary hypertension (PH) is characterized hemodynamically by significantly elevated pulmonary artery pressure, which if sustained can result in clinical deterioration due to progressive right-sided heart failure and death. Establishing the etiology of PH in a patient before treatment is imperative. Effective evidence-based therapeutic agents for treating PH have been developed. However, appropriately powered, randomized trials in PH associated with left-sided heart failure are sparse, and those that have been performed have shown no benefit or harm. An improved understanding of the pathophysiology, definition, and development of new therapies for treating PH associated with left-sided heart failure is urgently needed.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22748905     DOI： 10.1016/j.hfc.2012.04.009

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN： 1551-7136            Impact factor:   3.179


  7 in total

1.  Endothelin-1, cardiac morphology, and heart failure: the MESA angiogenesis study.

Authors:  Peter J Leary; Nancy S Jenny; David A Bluemke; Steven M Kawut; Richard A Kronmal; Joao A Lima; Bradley A Maron; David D Ralph; Samuel G Rayner; John J Ryan; Zachary L Steinberg; Karen D Hinckley Stukovsky; Ryan J Tedford
Journal:  J Heart Lung Transplant       Date:  2019-08-10       Impact factor: 10.247

Review 2.  Pulmonary Vascular Disease: Hemodynamic Assessment and Treatment Selection-Focus on Group II Pulmonary Hypertension.

Authors:  Bhavadharini Ramu; Brian A Houston; Ryan J Tedford
Journal:  Curr Heart Fail Rep       Date:  2018-04

3.  Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease.

Authors:  Arianne van Koppen; Diana A Papazova; Nynke R Oosterhuis; Hendrik Gremmels; Rachel H Giles; Joost O Fledderus; Jaap A Joles; Marianne C Verhaar
Journal:  Stem Cell Res Ther       Date:  2015-04-15       Impact factor: 6.832

4.  Left ventricular dysfunction in patients with suspected pulmonary arterial hypertension.

Authors:  Francisca Gavilanes; José Leonidas Alves; Caio Fernandes; Luis Felipe Lopes Prada; Carlos Viana Poyares Jardim; Luciana Tamie Kato Morinaga; Bruno Arantes Dias; Susana Hoette; Rogerio Souza
Journal:  J Bras Pneumol       Date:  2014 Nov-Dec       Impact factor: 2.624

5.  Intratracheal administration of isosorbide dinitrate improves pulmonary artery pressure and ventricular remodeling in a rat model of heart failure following myocardial infarction.

Authors:  Xuelian Wang; Qingqing Xu; Tianqi Li; Yaocong Rong; Weilin Hong; Yan Huang; Xingui Guo
Journal:  Exp Ther Med       Date:  2017-06-28       Impact factor: 2.447

6.  Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Pediatric Cardiology (SICP), and Italian Society of Gynaecologists and Obstetrics (SIGO): pregnancy and congenital heart diseases.

Authors:  Innocenzo Bianca; Giovanna Geraci; Michele Massimo Gulizia; Gabriele Egidy Assenza; Chiara Barone; Marcello Campisi; Annalisa Alaimo; Rachele Adorisio; Francesca Comoglio; Silvia Favilli; Gabriella Agnoletti; Maria Gabriella Carmina; Massimo Chessa; Berardo Sarubbi; Maurizio Mongiovì; Maria Giovanna Russo; Sebastiano Bianca; Giuseppe Canzone; Marco Bonvicini; Elsa Viora; Marco Poli
Journal:  Eur Heart J Suppl       Date:  2017-05-02       Impact factor: 1.803

7.  Transcriptome-wide analysis associates ID2 expression with combined pre- and post-capillary pulmonary hypertension.

Authors:  Meghan J Arwood; Nasim Vahabi; Christelle Lteif; Ravindra K Sharma; Roberto F Machado; Julio D Duarte
Journal:  Sci Rep       Date:  2019-12-20       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.